Your session is about to expire
← Back to Search
Intra-articular Injection of Axolotl Ambient for Osteoarthritis (Phoenix Trial)
Phoenix Trial Summary
This trial will compare the safety and effectiveness of a new potential treatment for ankle osteoarthritis (Axolotl Ambient) to a placebo.
Phoenix Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPhoenix Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Phoenix Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have a bone deficit.I am on prescription pain medication for a condition other than ankle osteoarthritis.I have had a hyaluronic acid injection in my joint within the last 6 months.I have had ankle pain for 6 months or more.I am using or willing to use effective birth control methods until the final follow-up.I have a history of cancer, other than skin cancer.I have an autoimmune disease that affects my bones or joints.I cannot walk 50 meters without help from a device.I have had major ankle surgery that could affect study results.I weigh less than 47 kg.I have a severe bone condition, like osteoporosis or avascular necrosis.I am not on medications that affect bone or cartilage, except for topical steroids.I need treatment like radiation, chemotherapy, or drugs that affect my immune system.I am willing to be assigned to any treatment group in the study.I am between 18 and 79 years old.I have been diagnosed with mild to moderate ankle arthritis.My most affected joint is one ankle, and it's the only one I plan to treat.I am willing and able to follow all study requirements.I am using or willing to use effective birth control methods until the final follow-up.I have had injections like PRP in my joint within the last year.My joint condition is severe or very severe according to a specific grading.I have arthritis near the same side of my joint problem that might affect the study.I agree to stop taking all pain meds for my ankle OA, except acetaminophen, which I won't take for 3 days before each visit.I've had a steroid injection in my joint within the last 3 months.I have not had surgery on my ankle in the last year.I am scheduled for an ankle procedure during the study.I need treatment for arthritis in both of my ankles.I have Charcot foot disease.I have a condition that causes body-wide inflammation.I have poor blood flow in my vessels.I am currently taking blood thinners.My spine is curved more than 30 degrees.I do not have an infection at the site of injection.
- Group 1: Control Group
- Group 2: Investigational Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are receiving therapy in this research project?
"That is correct. The online clinicaltrials.gov registry currently has this trial listed as open and recruiting. This particular study was posted on December 1st, 2021 and was updated on October 27th, 2022. There are 4 sites enrolling a total of 48 patients."
If a patient is not yet 45 years old, are they still eligible for this clinical trial?
"By meeting the age requirements of 18 years or older, and 80 years or younger, potential patients can adhere to the age bracket set by the inclusion criteria."
If I am eligible, can I sign up for this research opportunity?
"Those afflicted with arthrosis and aged between 18 and 80 may be eligible for this clinical trial, of which the researchers are looking for a total of 48 individuals."
Can people with the relevant medical condition still enroll in this trial?
"Yes. The trial, which was posted on December first 2021 and updated on October 27th 2022, is currently looking for 48 patients from 4 different medical centres."
Share this study with friends
Copy Link
Messenger